Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

After Elections, Germany’s Pharma Industry Faces Uncertain Future

This article was originally published in The Pink Sheet Daily

Executive Summary

German elections have led to the possibility of several coalition government constellations, but none are particularly good for the pharmaceutical industry.

You may also be interested in...



European Notebook: CHMP Opens Up A Bit; France Looks For $1B In Price Cuts; Spain Making Good On Pharma Debts

Europe's top scientific advisory panel, the CHMP, could reveal more of its thoughts on product approvals next year. French biopharma tries to stave off deep cuts in budgetary debate; Germany may consider more health reforms following recent elections; Invesco, Servier see exec changes

German Austerity Measures Continue As Firms Dispute How Much Has Already Been Saved

Despite overall economic growth, the German health ministry refuses to lift the pharmaceutical price freeze or obligatory rebate to health insurers, saying industry is coping well with them; firms say they have already sacrificed more than had initially been asked.

Success Of German Cost-Control Law Raises Prospect Of Further Cuts For Pharma

Germany's 2011 pharmaceutical prescribing report shows that the cost control law (AMNOG) is fulfilling its purpose, prompting insurers to call for even further pressure on the industry to reduce costs.

Related Content

Topics

UsernamePublicRestriction

Register

PS076280

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel